November 11, 2016 / 1:46 PM / 3 years ago

BRIEF-Adaptimmune presents preclinical data from SPEAR T-cell

Nov 11 (Reuters) - Adaptimmune Therapeutics Plc

* Adaptimmune presents preclinical data from a new, wholly-owned Spear T-cell and a second generation spear T-cell at the 31st annual meeting of the Society For Immunotherapy for Cancer (sitc)

* Adaptimmune Therapeutics PLC - Plan to file an IND in early 2017

* Adaptimmune Therapeutics PLC - NY-ESO spear T-cells have shown promising activity in clinical trials for both solid and liquid tumors Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below